Hebrew University of Jerusalem
The Hebrew University, Mt. Scopus
Jerusalem
91905
73 articles about Hebrew University of Jerusalem
-
Beyond Air® Licenses Commercial Rights to Selective Neuronal Nitric Oxide Synthase (nNOS) Inhibitors for the Treatment of Autism Spectrum Disorder from Hebrew University of Jerusalem
6/15/2023
Beyond Air, Inc. announced that it has entered into an agreement with Yissum Research Development Company of the Hebrew University of Jerusalem, LTD. to license the commercial rights for multiple neuronal nitric oxide synthase inhibitor candidates, currently being developed for the treatment of autism spectrum disorder and other neurological conditions.
-
BNS and RAFARM create BNS Ophthalmics to leverage nanotechnology in the development of novel ophthalmic products
5/30/2023
RAFARM and BioNanoSim, an Israeli-based nanotechnology drug discovery and development company co-founded by Prof. Simon Benita and Yissum, the Transfer Technology and IP company of The Hebrew University of Jerusalem, have entered into an agreement to create a new Ophthalmic company called BNS Ophthalmics.
-
Israel-Based Clearmind Successfully Completed Two R&D Projects With The Hebrew University of Jerusalem’s Tech Transfer Company, Yissum
1/19/2023
Clearmind Medicine Inc. announced the successful completion of two R&D projects with leading scientists from multiple disciplines at the Hebrew University as part of a collaboration established with the university’s technology transfer company, Yissum.
-
Covid-19, aging, stroke, ALS, colorectal cancers and Alzheimer's disease are all the focus of this week's top research stories.
-
Researchers continue to explore how to turn deadly venom into life-saving drugs. Several papers on the subject have recently been published and BioSpace is taking a look at them.
-
Hebrew University Team Teaches an Old Drug New Tricks
5/4/2020
New Delivery for Antibiotics Arms Medicine in the Fight against Antibiotic Resistance and COVID-19
-
Hebrew University Researchers Submit Proposals to Israel Innovation Authority to Investigate Diagnostics, Treatments, and Cures for Covid-19
3/26/2020
Researchers at The Hebrew University of Jerusalem as well as several Yissum start-up companies are exploring a variety of methods to combat the COVID-19 virus, through investigations into AI drug discovery, biochemical detection tools and diagnostic capabilities.
-
New research casts doubt on near reality of 'designer babies'
11/21/2019
The Feinstein Institutes for Medical Research Professor Todd Lencz, PhD, in collaboration with The Hebrew University of Jerusalem, evaluated the probability of using contemporary genetic technology to select human embryos on the basis of complex traits, such as intelligence and height.
-
Dapagliflozin Reduces Progression of Kidney Disease and Renal Death in People with Type 2 Diabetes
6/10/2019
Sub-analysis of data from DECLARE-TIMI 58 trial shows a 47% reduction of composite kidney function decline, end-stage renal disease or death, presented today at the ADA's Scientific Sessions
-
Yissum Hosts First-of-its-Kind Conference to Drive Academic-industry Collaboration in Cannabis Research & Development
5/1/2019
Yissum and Hebrew University Lead Cannabis Technology Transfer as Holders of the Most Academic Patents Worldwide
-
Hebrew University to Collaborate With KYORIN
12/27/2018
Strategic partnership aims to develop respiratory drug therapies
-
The Hebrew University of Jerusalem installs MILabs’ dual-energy, ultra-high resolution microCT
7/30/2018
A MILabs dual-energy, ultra-high resolution U-CT system has been installed at the Hebrew University of Jerusalem Israel (HUJI). Under the direction of Professor Galia Blum, this institute has established an internationally renowned research program, focused on drug design, delivery, and therapy.
-
Daniel Schlessinger Elected Chair of Hebrew University Board of Governors
6/19/2018
The law firm of Jaszczuk P.C. is exceptionally proud to announce that the Board of Governors of Hebrew University has unanimously elected Daniel I. Schlessinger as the University’s next Chair of the Board of Governors.
-
Yissum Announces New Platform for 3D Printing of Personalized Food
10/23/2017
Yissum introduced today a novel technology for the 3D printing of personalized food based on nano-cellulose, a natural, edible, calorie-free fiber.
-
Agreement Reached Between The Hebrew University of Jerusalem And The University Of Montreal And New Collaborations With IRIC
5/24/2017
-
Israeli Researcher Invents Devices Allowing Blind People To "See" Via Vibrations, Sounds, Hebrew University of Jerusalem Study
9/16/2016
-
Why So Many Israelis Get Blood Cancer, Hebrew University of Jerusalem Study
8/31/2016
-
Magnet Next To Blood Clot Pulls Enzymes Encased In Magnetite, Dissolves Clot, Hebrew University of Jerusalem Study
4/11/2016
-
Human Stem Cell With Half A Genome Could Help Infertile Couples, Hebrew University of Jerusalem Study
3/17/2016
-
Hebrew University of Jerusalem Release: New Method Detects Multiple Diseases Via DNA Released From Dying Cells Into Blood
3/15/2016